Distinguishing non-small cell lung adenocarcinoma patients from squamous cell carcinoma patients and control individuals using serum profiling.

Abstract

Goals of this study were to analyze the ability of mass spectrometry serum profiling to distinguish non-small cell lung adenocarcinoma from squamous cell carcinoma patients and healthy controls. Sera were obtained from 19 adenocarcinoma patients, 24 squamous cell carcinoma patients, and 21 controls. Identifications of significant mass-to-charge ratio (m/z) peak differences between these groups were performed using t-tests. A "leave one out" cross-validation procedure yielded discriminatory lung adenocarcinoma versus squamous cell carcinoma p and ROC curve values of <.0001 and 0.92, respectively. Test sensitivity and specificity were 84% and 79%, respectively. This approach could aid in lung cancer diagnosis and sub-typing.

• Authors: James R Hocker, Marvin D Peyton, Megan R Lerner, Stan A Lightfoot, Rushie J Hanas, Daniel J Brackett, Jay S Hanas
• Journal: Cancer investigation (Cancer Invest) Vol. 30 Issue 2 Pg. 180-8 (Feb 2012) ISSN: 1532-4192 [Electronic] England
• PMID: 22149138 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't, Research Support, U.S. Gov't, Non-P.H.S.)

Topics

• Adenocarcinoma (blood, diagnosis, pathology)
• Adenocarcinoma of Lung
• Adult
• Aged
• Aged, 80 and over
• Carcinoma, Squamous Cell (blood, diagnosis, pathology)
• Case-Control Studies
• Diagnosis, Differential
• Female
• Humans
• Lung Neoplasms (blood, diagnosis, pathology)
• Male
• Mass Spectrometry (methods)
• Middle Aged